AlzeCure Presents New Clinical Data with NeuroRestore ACD856 at the Alzheimer's Conference AAIC
Accesswire
*STOCKHOLM, SWEDEN / ACCESSWIRE / August 2, 2022 /* AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)
*AlzeCure Pharma AB (publ) (FN..
*STOCKHOLM, SWEDEN / ACCESSWIRE / August 2, 2022 /* AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)
*AlzeCure Pharma AB (publ) (FN..